VC-backed Prevail Therapeutics promotes Dai to CTO
New York City-based Prevail Therapeutics Inc, a gene therapy company, has promoted Dr. Yong Dai to chief technology officer. Also, the company has named Tim Adams to its board of directors as audit committee chair while Dr. Francois Nader, a member of the board, will expand his role as non-executive chairman. Prevail's backers include OrbiMed, Pontifax Fund, RA Capital Management, EcoR1 Capital, Omega Funds, BVF Partners LP, Boxer Capital LLC, Adage Capital Management LP and Alexandria Venture Investments.
16 May 2019•4 mins read
